Skip to main content
SpringerLink
Log in

Bupropion/diltiazem/venlafaxine

Vasodilatory cardiogenic mixed shock, lactic acidosis and multiorgan dysfunction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Quinn C, et al. Successful use of angiotensin II in a case of refractory vasodilatory cardiogenic mixed shock. Critical Care Medicine 49 (Suppl.): 646 abstr. 1280, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1097/01.ccm.0000731008.71855.c1 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bupropion/diltiazem/venlafaxine. Reactions Weekly 1853, 103 (2021). https://doi.org/10.1007/s40278-021-94969-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-94969-2

Search

Navigation